Becton, Dickinson and Company
$155.63
▼
-0.68%
2026-04-22 10:12:13
www.bd.com
NYQ: BDX
Explore Becton, Dickinson and Company stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$44.7 B
Current Price
$155.63
52W High / Low
$187.35 / $127.54
Stock P/E
25.5
Book Value
$88.79
Dividend Yield
2.65%
ROCE
6.35%
ROE
6.96%
Face Value
—
EPS
$6.12
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
70,000
Beta
0.35
Debt / Equity
77.28
Current Ratio
1.05
Quick Ratio
0.64
Forward P/E
11.42
Price / Sales
2.55
Enterprise Value
$62.7 B
EV / EBITDA
10.38
EV / Revenue
2.86
Rating
Buy
Target Price
$196.08
EPS Forecast (FY)
—
Pros
- Meaningful dividend yield is available.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Sanara MedTech Inc. | $20.62 | — | $190.4 M | — | 16.84% | -1.75% | $35.95 / $16.05 | $0.66 |
| 2. | Zentek Ltd. | $0.5 | — | $73.33 M | — | -64.39% | -56.64% | $2.5 / $0.63 | $0.08 |
| 3. | Microbot Medical Inc. | $2.3 | — | $154.46 M | — | -18.87% | -32.42% | $4.67 / $1.6 | $1.16 |
| 4. | Regentis Biomaterials Ltd. | $2.96 | — | — | — | -181.68% | 75.07% | $8.35 / $2.8 | $0.92 |
| 5. | Harvard Bioscience, Inc. | $6.99 | — | $30.92 M | — | 0.17% | -1.47% | $9.46 / $2.81 | $3.07 |
| 6. | Retractable Technologies, Inc. | $0.65 | — | $19.46 M | 1.18% | -10.73% | -15.56% | $1.14 / $0.62 | $2.48 |
| 7. | The Cooper Companies, Inc. | $67.65 | 33.54 | $13.23 B | 0.02% | 6.05% | 4.87% | $89.83 / $61.78 | $42.87 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 5.25 B | 5.89 B | 5.51 B | 5.27 B | 5.17 B | — |
| Operating Profit | 662 M | 826 M | 979 M | 637 M | 546 M | — |
| Net Profit | 382 M | 493 M | 574 M | 308 M | 303 M | — |
| EPS in Rs | 1.34 | 1.73 | 2.02 | 1.08 | 1.07 | 1.45 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 21.84 B | 20.18 B | 19.37 B | 18.87 B |
| Operating Profit | 2.99 B | 2.86 B | 2.42 B | 2.48 B |
| Net Profit | 1.68 B | 1.71 B | 1.48 B | 1.78 B |
| EPS in Rs | 5.9 | 5.99 | 5.22 | 6.25 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 55.33 B | 57.29 B | 52.78 B | 52.93 B |
| Total Liabilities | 29.93 B | 31.4 B | 26.98 B | 27.65 B |
| Equity | 25.39 B | 25.89 B | 25.8 B | 25.28 B |
| Current Assets | 9.26 B | 10.47 B | 8.68 B | 8.14 B |
| Current Liabilities | 8.31 B | 8.96 B | 6.64 B | 7.81 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 3.43 B | 3.8 B | 2.99 B | 2.63 B |
| Investing CF | -818 M | -5.51 B | -716 M | -3.23 B |
| Financing CF | -3.62 B | 2.09 B | -1.96 B | -591 M |
| Free CF | 2.67 B | 3.07 B | 2.12 B | 1.66 B |
| Capex | -760 M | -725 M | -874 M | -973 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 4.16% | 2.66% | — | — |
| Earnings Growth % | 14.89% | -16.58% | — | — |
| Profit Margin % | 8.45% | 7.66% | 9.43% | — |
| Operating Margin % | 14.15% | 12.51% | 13.12% | — |
| Gross Margin % | 45.22% | 42.17% | 44.92% | — |
| EBITDA Margin % | 23.88% | 22.72% | 23.37% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-03-10 | $1.05 |
| 2025-12-08 | $0.8255 |
| 2025-09-08 | $0.8176 |
| 2025-06-09 | $0.8176 |
| 2025-03-10 | $0.8176 |
Stock Splits
| Date | Split |
|---|---|
| 2026-02-10 | 1:1.272 |
| 2022-04-01 | 1:1.025 |